rs10788338
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000444384.3(SFTPD):c.36+9309T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.666 in 151,908 control chromosomes in the GnomAD database, including 34,697 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.67 ( 34696 hom., cov: 31)
Exomes 𝑓: 1.0 ( 1 hom. )
Consequence
SFTPD
ENST00000444384.3 intron
ENST00000444384.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.41
Publications
7 publications found
Genes affected
SFTPD (HGNC:10803): (surfactant protein D) The protein encoded by this gene is part of the innate immune response, protecting the lungs against inhaled microorganisms and chemicals. The encoded protein may also be involved in surfactant metabolism. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.06).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.836 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SFTPD | XM_011540087.2 | c.-4+8952T>G | intron_variant | Intron 1 of 7 | XP_011538389.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.665 AC: 101014AN: 151788Hom.: 34636 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
101014
AN:
151788
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 1.00 AC: 2AN: 2Hom.: 1 AF XY: 1.00 AC XY: 2AN XY: 2 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
2
Hom.:
AF XY:
AC XY:
2
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
2
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.666 AC: 101135AN: 151906Hom.: 34696 Cov.: 31 AF XY: 0.665 AC XY: 49362AN XY: 74218 show subpopulations
GnomAD4 genome
AF:
AC:
101135
AN:
151906
Hom.:
Cov.:
31
AF XY:
AC XY:
49362
AN XY:
74218
show subpopulations
African (AFR)
AF:
AC:
34979
AN:
41454
American (AMR)
AF:
AC:
9431
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
2102
AN:
3466
East Asian (EAS)
AF:
AC:
3197
AN:
5158
South Asian (SAS)
AF:
AC:
3570
AN:
4810
European-Finnish (FIN)
AF:
AC:
5765
AN:
10500
Middle Eastern (MID)
AF:
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39931
AN:
67944
Other (OTH)
AF:
AC:
1384
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1622
3243
4865
6486
8108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2495
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.